The generic drug industry is warning that Democrats' drug pricing legislation would undercut their ability to compete against brand-name drugs, and some experts say they have a point.
READ MORE
Remember Me
4/5/2023Pandemic Saw Rise in Opioid Prescriptions Given After Childbirth
10/6/2025USP 800: What Community Pharmacies Need to Know
10/6/2025Illegible Signature? Auditors Are Taking Note!
10/6/2025CDC Immunization Schedule Adopts Individual-Based Decision-Making for Vaccines
10/2/2025Pfizer-Trump Deal Blindsides Other Drug Companies
11/8/2025UPhA 2025 Mid-Year Meeting
2023 UPhA Awards Nomination Form
Print Page
Email to a Friend